And she's based in the US where the pivotal short 2 week study will be conducted. I read yesterday that it was stated that there are plenty of patients with STS and high fap ready to go on the American sites.
Question though, if they know they are high in fap are they already using fap imaging tech? (Probably read eggy's arthritis concerns and started using it)
Have to say over the years being in or out of the MSCI has made very little difference to the share price. Certainly nothing to get excited about other than it putting avacta on the radar of some desks I suppose.